HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marian Danilewicz Selected Research

nucleolar organizer region associated proteins

2/2014The AgNORs count in predicting long-term survival in serous ovarian cancer.
10/2004[Assessment of the AgNORs count in serous ovarian cancer].
9/2003[Assessment of the influence of chemotherapy on the nucleolar organizer regions (AgNORs) count in serous ovarian cancer cells].
1/2003AgNORs count correlates better than grading with the effect of chemotherapy in serous ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marian Danilewicz Research Topics

Disease

24Neoplasms (Cancer)
01/2021 - 01/2002
8Inverted Papilloma
10/2016 - 01/2010
8IGA Glomerulonephritis (IGA Nephropathy)
01/2010 - 01/2002
7Ovarian Neoplasms (Ovarian Cancer)
02/2014 - 01/2003
6Fibrosis (Cirrhosis)
01/2017 - 01/2004
5Glomerulonephritis
11/2021 - 01/2002
5Neoplasm Metastasis (Metastasis)
01/2021 - 01/2002
5Bullous Pemphigoid (Pemphigoid)
01/2015 - 01/2009
5Dermatitis Herpetiformis (Disease, Duhring's)
01/2015 - 01/2009
5Lupus Nephritis
01/2009 - 01/2005
4Proteinuria
11/2021 - 01/2004
4Laryngeal Neoplasms (Laryngeal Cancer)
10/2016 - 01/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2016 - 01/2010
3Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
11/2021 - 01/2006
3Squamous Cell Carcinoma of Head and Neck
09/2018 - 01/2002
3Carcinogenesis
01/2013 - 10/2007
3Carcinoma (Carcinomatosis)
01/2011 - 01/2002
3Membranous Glomerulonephritis (Membranous Nephropathy)
01/2009 - 01/2007
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2012
2Hypertension (High Blood Pressure)
11/2021 - 01/2017
2Gynecomastia
01/2019 - 01/2018
2Prostatic Neoplasms (Prostate Cancer)
03/2015 - 01/2013
2Hypersensitivity (Allergy)
01/2012 - 01/2006
2Nasal Polyps (Nasal Polyp)
01/2012 - 01/2006
2Papillomavirus Infections
01/2011 - 01/2010
2Disease Progression
01/2011 - 03/2009
2Colorectal Neoplasms (Colorectal Cancer)
12/2010 - 10/2007
2Nephritis
01/2010 - 01/2002
2Cystadenoma
01/2010 - 01/2008
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2007 - 01/2006
2Inflammation (Inflammations)
01/2007 - 01/2006
2Amyloidosis
01/2006 - 01/2002
1Breast Neoplasms (Breast Cancer)
01/2022
1Chronic Pancreatitis
01/2022
1Adenocarcinoma
01/2022
1Body Weight (Weight, Body)
11/2021
1Interstitial Nephritis (Tubulointerstitial Nephritis)
11/2021
1Respiratory Insufficiency (Respiratory Failure)
11/2021
1COVID-19
11/2021
1Acute Kidney Injury (Acute Renal Failure)
11/2021
1Hypertrophy
03/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1Hyperplasia
10/2018
1Edema (Dropsy)
10/2018
1Oral Leukoplakia
09/2018
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
6ParaffinIBA
02/2016 - 01/2009
6Monoclonal AntibodiesIBA
12/2010 - 01/2002
5IntegrinsIBA
01/2013 - 01/2002
4CreatinineIBA
11/2021 - 01/2005
4nucleolar organizer region associated proteinsIBA
02/2014 - 01/2003
3DNA (Deoxyribonucleic Acid)IBA
08/2016 - 01/2010
3Formaldehyde (Formol)FDA Link
02/2016 - 01/2010
3Matrix Metalloproteinases (MMPs)IBA
01/2010 - 03/2003
2Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2012
2Biological ProductsIBA
01/2021 - 03/2015
2EnzymesIBA
10/2016 - 01/2012
2Cadherins (E-Cadherin)IBA
10/2016 - 01/2008
2MetallothioneinIBA
11/2015 - 06/2015
2SurvivinIBA
03/2015 - 01/2013
2AntigensIBA
03/2015 - 01/2014
2SilverIBA
02/2014 - 02/2013
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2012 - 01/2006
2Transforming Growth Factor beta (TGF-beta)IBA
10/2007 - 01/2006
2Amyloid (Amyloid Fibrils)IBA
01/2007 - 01/2002
2Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2007 - 01/2005
2Chemokine CCL5IBA
01/2007 - 01/2005
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2006 - 01/2005
2Immunoglobulin A (IgA)IBA
01/2005 - 01/2002
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2005 - 01/2005
1Hormones (Hormone)IBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2021
1GlucocorticoidsIBA
11/2021
1Anabolic Androgenic SteroidsIBA
11/2021
1Apolipoprotein L1IBA
11/2021
1Prednisone (Sone)FDA LinkGeneric
11/2021
1MethylprednisoloneFDA LinkGeneric
11/2021
1Aromatase InhibitorsIBA
03/2020
1Gonadal Steroid Hormones (Sex Hormones)IBA
03/2020
1poly(propyleneimine)IBA
01/2020
1maltotrioseIBA
01/2020
1Dendrimers (Dendrons)IBA
01/2020
1fludarabineIBA
01/2020
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1Estrogens (Estrogen)FDA Link
01/2019
1Estradiol (Delestrogen)FDA LinkGeneric
10/2018
1AntibodiesIBA
09/2018
1NeuropilinsIBA
01/2018
1DisintegrinsIBA
01/2018
1TamoxifenFDA LinkGeneric
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1Metalloproteases (Metalloproteinases)IBA
01/2018
1Neuropilin-1IBA
01/2018
1ChromatinIBA
01/2017

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2018 - 01/2003
3Operative Surgical Procedures
10/2004 - 01/2003
2Therapeutics
11/2021 - 10/2016
1High-Protein Diet
11/2021